Suerte, Baby Charlyn P.
HRN: 22-01-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/02/2024
12/09/2024
IV
150mg
Q8H
Second Degree Burn
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes